Manoj S Chiney

ORCID: 0000-0003-3679-9363 · 2 papers in corpus
other 2022
Biopharmaceutics & drug disposition ·doi:10.1002/bdd.2315

The aim of this analysis was to use a physiologically based pharmacokinetic (PBPK) model to predict the impact of changes in dissolution rates on elagolix exposures and define clinically relevant acceptance criteria for dissolution. Varying…

other 2020
Clinical pharmacokinetics ·doi:10.1007/s40262-019-00833-6

INTRODUCTION: Elagolix is approved for the management of moderate-to-severe pain associated with endometriosis. The aim of this analysis was to develop a physiologically based pharmacokinetic (PBPK) model that describes the enzyme-transport…